THE EZH2 REPRESSIVE CHROMATIN SIGNATURE MAY PREDISPOSE THE RUNX3 PROMOTER TO METHYLATION BUT IS NOT INDEPENDENTLY RESPONSIBLE FOR ITS TRANSCRIPTIONAL SILENCING IN COLORECTAL CANCER

(1) Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden

(2) Department of Pathology, Academic Medical Center, Amsterdam

(3) Department of Pathology, Utrecht University Medical Center, Utrecht, Netherlands



This item was part of the Mechanisms of colorectal carcinogenesis session at Gastro 2009 UEGW/WCOG London (17th UEGW)

This item can be cited as: Gut 2009; 58 (Suppl II) A22

You may be interested in:

Irritable bowel syndrome (IBS)
English, Presentation, Clinical aspects, Medical management, Investigation and Diagnosis, Irritable Bowel Syndrome, 2013

Categorisation:

  • Format
    • Abstract
  • Language
    • English
  • Year
    • 2009